首页> 外文期刊>American journal of respiratory and critical care medicine >Addressing the Complexity of Chronic Obstructive Pulmonary Disease From Phenotypes and Biomarkers to Scale-Free Networks, Systems Biology, and P4 Medicine
【24h】

Addressing the Complexity of Chronic Obstructive Pulmonary Disease From Phenotypes and Biomarkers to Scale-Free Networks, Systems Biology, and P4 Medicine

机译:从表型和生物标记物到无标度网络,系统生物学和P4医学,解决慢性阻塞性肺疾病的复杂性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Chronic obstructive pulmonary disease (COPD) is a complex disease at the clinical, cellular, and molecular levels. However, its diagnosis, assessment, and therapeutic management are based almost exclusively on the severity of airflow limitation. A better understanding of the multiple dimensions of COPD and its relationship to other diseases is very relevant and of high current interest. Recent theoretical (scale-free networks), technological (high-throughput technology, biocomputing), and analytical improvements (systems biology) provide tools capable of addressing the complexity of COPD. The information obtained from the integrated use of those techniques will be eventually incorporated into routine clinical practice. This review summarizes our current knowledge in this area and offers an insight into the elements needed to progress toward an integrated, multilevel view of COPD based on the novel scientific strategy of systems biology and its potential clinical derivative, P4 medicine (Personalized, Predictive, Preventive, and Participatory).
机译:慢性阻塞性肺疾病(COPD)在临床,细胞和分子水平上都是一种复杂的疾病。但是,其诊断,评估和治疗管理几乎完全基于气流受限的严重程度。对COPD的多个方面及其与其他疾病的关系的更好的了解是非常相关的,并且具有很高的兴趣。最近的理论(无标度网络),技术(高通量技术,生物计算)和分析改进(系统生物学)提供了能够解决COPD复杂性的工具。从这些技术的综合使用中获得的信息最终将被纳入常规临床实践中。这篇综述总结了我们在该领域的当前知识,并根据系统生物学的新科学策略及其潜在的临床衍生产品P4药物(个性化,预测性,预防性),深入探讨了对COPD进行多层次综合观察所需的要素。和参与式)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号